Toxins News and Research

RSS

Flavoring can change how the brain responds to nicotine e-cigarettes

Flavoring can change how the brain responds to e-cigarette aerosols that contain nicotine, according to Penn State College of Medicine researchers.

23 Jun 2021

Caterpillar’s venom shows promise for use in medicines, pest control

The venom of a caterpillar, native to South East Queensland, shows promise for use in medicines and pest control, Institute for Molecular Bioscience researchers say. The Doratifera vulnerans is common to large parts of Queensland's south-east and is routinely found in Toohey Forest Park on Brisbane's southside.

23 Jun 2021

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Iksuda Therapeutics today announced that it has expanded its research collaboration and License Agreement with LegoChem Biosciences, Inc.

From Iksuda Therapeutics 22 Jun 2021

New human organoid mimics the earliest developmental steps of the nervous system in embryos

The progression from a round ball of cells to an embryo with a head and a tail is one of the most critical steps in an organism's development. But just how cells first start organizing themselves with directionality along this head-to-tail axis is hard to study because it happens in the earliest days of embryonic development, in the confines of a mammal's uterus.

22 Jun 2021

Irritable bowel syndrome is linked to bacterial biofilms in the gut

One in six women and one in twelve men in Austria suffers from some form of IBS - therefore around one million people in all. Using currently available techniques, it is only possible to diagnose IBS by a process of elimination.

21 Jun 2021

Proven treatment for psychosis has been recognized as standard of care

Most people with a serious mental illness like schizophrenia will not obtain adequate care. Many end up in correctional facilities on medication or become homeless.

18 Jun 2021

Immune cell-mimicking nanoparticles deliver drugs directly to inflamed lungs

Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.

17 Jun 2021

P-glycoprotein shows ability to remove a toxin associated with Alzheimer's from the brain

\A team of SMU biological scientists has confirmed that P-glycoprotein (P-gp) has the ability to remove a toxin from the brain that is associated with Alzheimer's disease.

16 Jun 2021

Study reveals structural details of omega-3 fatty acid transport across the blood–brain barrier

Spectacular images of a molecule that shuttles omega-3 fatty acids into the brain may open a doorway for delivering neurological therapeutics to the brain.

16 Jun 2021

Repressing a protein that facilitates DNA repair to potentiate chemotherapy

Chemotherapy kills tumor cells by causing damage to them. One of the most effective ways of causing damage is to prevent the two DNA strands from separating so that the cellular machinery cannot read the instructions written in the genes.

15 Jun 2021

Prenatal exposure to air pollutants may increase infants' obesity risk

Women exposed to higher levels of air pollution during pregnancy have babies who grow unusually fast in the first months after birth, putting on excess fat that puts them at risk of obesity and related diseases later in life, new CU Boulder research shows.

15 Jun 2021

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

A newly developed radiotracer can measure increases in brain tau at least a year prior to the emergence of other symptoms.

15 Jun 2021

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

The liver is the most resilient organ in the human body. It can remove toxins from the bloodstream, recycle red blood cells, maintain sugar levels, and it can even regenerate itself. But, when a large amount of fat builds up in the liver, it becomes too inflamed to perform its crucial duties.

14 Jun 2021

Nicotinamide can help stimulate plant immune systems, shows study

Fungal diseases in cereal crops cause major economic losses and also threaten human and livestock health, because some fungi produce powerful toxins that might enter the food chain. Farmers use fungicides to control crop diseases, such as wheat head blight. Although agrochemicals are rigorously tested for safety, there can be concerns over chemical residues in food.

11 Jun 2021

Microgel-coated mesenchymal stromal cells can reverse pulmonary fibrosis

Researchers at the University of Illinois Chicago have shown that even after lung tissue has been damaged, it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells.

9 Jun 2021

Restoration can improve mining contamination, indicates study

Mining involves moving a lot of rock, so some mess is expected. However, mining operations can continue to affect ecosystems long after activity has ended. Heavy metals and corrosive substances leach into the environment, preventing wildlife and vegetation from returning to the area.

9 Jun 2021

Cows can pass on hypoglycin A toxin through their milk, shows study

Cows can pass on the hypoglycin A toxin through their milk, a study by the Martin Luther University Halle-Wittenberg (MLU) and the Leibniz Institute of Plant Biochemistry (IPB) in Toxins shows. The substance can cause severe symptoms in humans and animals.

8 Jun 2021

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic.

3 Jun 2021

New NIH grant aims to mitigate factors that cause dialysis patients to die

The five-year survival rate for people on dialysis is under 50 percent. University of California researchers are hoping to improve that prognosis.

2 Jun 2021

Weaker association between brain activity and cerebrospinal fluid flow increases the likelihood of Alzheimer's disease

New imaging research shows that brain activity during sleep was less connected with cerebrospinal fluid flow in patients with Alzheimer's disease.

1 Jun 2021

Toxins News and Research

Flavoring can change how the brain responds to nicotine e-cigarettes

Caterpillar’s venom shows promise for use in medicines, pest control

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

New human organoid mimics the earliest developmental steps of the nervous system in embryos

Irritable bowel syndrome is linked to bacterial biofilms in the gut

Proven treatment for psychosis has been recognized as standard of care

Immune cell-mimicking nanoparticles deliver drugs directly to inflamed lungs

P-glycoprotein shows ability to remove a toxin associated with Alzheimer's from the brain

Study reveals structural details of omega-3 fatty acid transport across the blood–brain barrier

Repressing a protein that facilitates DNA repair to potentiate chemotherapy

Prenatal exposure to air pollutants may increase infants' obesity risk

Novel biomarker effectively detects Alzheimer's disease before symptoms emerge

Virginia Tech researcher receives $2.2 million to advance study on small 'fat burning' molecules

Nicotinamide can help stimulate plant immune systems, shows study

Microgel-coated mesenchymal stromal cells can reverse pulmonary fibrosis

Restoration can improve mining contamination, indicates study

Cows can pass on hypoglycin A toxin through their milk, shows study

Centivax and US Naval Medical Research Center to begin Phase I clinical trial of antibody therapeutics

New NIH grant aims to mitigate factors that cause dialysis patients to die

Weaker association between brain activity and cerebrospinal fluid flow increases the likelihood of Alzheimer's disease

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News